Even with the Dow down nearly 270 points yesterday, TRMA closed up almost 4%. The TRMA chart is a classic pincher play setup that is looking to reverse. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=429 Let us hear your thoughts below:
Tombstone Exploration Corp. announced this morning that it has contracted Geotech Ltd. of Ontario, Canada to fly an airborne Z-Axis Tipper Electromagnetic (ZTEM) on its Tombstone, Arizona property. ZTEM is known for its ability to achieve unparalleled resolution and depth of investigation, capable of gathering data over 6,000 feet (2 kilometers) below ground surface. Geotech arrived at the Tombstone property earlier this week. The airborne survey will be over 200 line miles, covering most of the Tombstone district. The data will be interpreted to provide targets for a giant, high-grade porphyry copper - gold deposit that can be mined by…
Vidaroo Corp. is an emerging leader in integrated digital media and technology solutions, with vast expertise in marketing, content creation, post-production, which is structured around one driving central premise held dear by both the Board of Directors and executive management, as well as its entire staff: sustainable profitability. An intuitive yet robust online video platform for managing and delivering content, the Company’s sophisticated Digital Video Publisher enables users to extend existing sites into web-based TV networks. With easily embeddable channels and video, users can reach massive new markets through viral promotion and organic information seeding on social networking sites. With…
Stocks continued their slump in Tuesday’s mid-day trading after data reporting that U.S. consumer confidence fell in June, paired with concern over Europe’s fiscal challenges. An hour from the market close, the Dow (DJI) lost 236.93 points, 2.43 percent, to 9,901.59, marking the first time the index dropped below 10,000 since June 10; the S&P 500 gave up 28.81 points, or 2.68 percent, to 1,045.07; and the Nasdaq fell 72.99 points, 3.29 percent to 2,147.43. U.S. stocks are set to post their first quarterly decline since the first quarter of 2009, curtailing from four consecutive quarters of gains; and second-quarter…
Cellceutix Corp. develops small molecule therapies for treatment of cancer, autism and inflammatory disease. The company is supported by a panel of officers and advisors with extensive experience and knowledge in the fields of cancer and genetics, as well as with wide experience in the pharmaceutical business and relative researching, developing and marketing. Most of the company’s efforts center on the company’s lead product Kevetrin, which is in development for drug-resistant cancers. Cellceutix is concluding final studies before applying for FDA approval for human studies. The company’s focus is maintained by a strong management team and a shared commitment to…
OriginOil, Inc., www.originoil.com – a leader in the breakthrough technology of using large-scale algae farming techniques for the production of renewable oil that can directly compete with petroleum, announced the appointment of Brian Goodall, Ph.D. as its new CTO today. As OOIL’s strategic partner, Desmet Ballestra North America, Inc. President and CEO Timothy Kemper, puts it, Brian Goodall has prior experience working closely with them when he was VP of Downstream Technology at Sapphire Energy, and has Kemper’s “personal confidence and support”. Goodall’s work at Sapphire with Continental Airlines led to the first commercial US flight demo using an algae-oil…
Public Media Works, Inc., www.publicmediaworks.com – the technologically-forward leader in entertainment which also distributes demographically relevant digital media via subsidiary, EntertainmentXpress (using a self-service kiosk architecture), disclosed details about the signing of a Letter of Intent to acquire Ventures, Inc., DBA VideomaticCanada, today. Consistent with ongoing PUBM due diligence, the companies anticipate an all-stock transaction within six to eight weeks. Current growth rate projections indicate that VideomaticCanada is well on its way to achieving the goal, set by management, of becoming Canada’s largest DVD kiosk network in 2010. VideomaticCanada is currently Canada’s second largest DVD and videogame kiosk network, with…
US Dataworks, Inc. reported net income of $85,379 or $0.00 per share, in the first quarter that ended 3/31/2010. The company reported a net loss of $181,221, or $0.01 per share, in the corresponding quarter of 2009. Revenue increased on a year over year basis in the first quarter of 2010 to $2.1 million from the $1.8 million reported in the first quarter of 2009. The segment showing the biggest improvement was the software licensing business. Charles E. Ramey, the CEO of US Dataworks, Inc. sounded upbeat about the upcoming year for the company. “We entered fiscal 2010 as a…
China Cablecom Holdings, Ltd. reported that sales in the first quarter of 2010 were $13.4 million, compared to $10 million in the first quarter of 2009. The management of the company attributed the large increase to strong growth in its subscriber base, and higher subscription and installation fees. Clive Ng, the Executive Chairman of China Cablecom Holdings, Ltd., said, “We are so pleased to be reporting such a strong quarter. The performance of both operations in Binzhou and Hubei have exceeded our expectations and delivered significant growth in revenues, EBITDA, subscription, digitization and ARPU.” China Cablecom Holdings, Ltd. reported that…
One company that is starting to earn attention within the pharmaceutical sector is Alimera Sciences, Inc. Located in Alpharetta, Georgia, Alimera is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Today, Alimera took a major step towards enhancing its future with the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Iluvien. Iluvien is Alimera’s investigational sustained drug delivery system releasing sub-microgram levels of fluocinolone acetonide for the treatment of diabetic macular edema (DME). In the submission, Alimera requested priority review, which, if granted, could result…
